Medications to Decrease Coughing in COPD Patients

First-Line Bronchodilator Options

The American College of Chest Physicians recommends ipratropium bromide as first-line therapy to improve cough in stable COPD patients, with a grade A recommendation 1, 2
Ipratropium bromide has demonstrated substantial benefit for cough reduction in patients with chronic bronchitis, with a significant decrease in the volume of sputum expectorated and reduction in cough frequency and severity 1, 2
Short-acting β-agonists may help control cough in some patients, but their effects on cough are less consistent than ipratropium bromide 1, 3

The American College of Chest Physicians suggests that if response to ipratropium bromide is inadequate, consider adding a short-acting β-agonist for additional bronchodilation and potential cough relief 1, 2
Theophylline can be considered to control chronic cough in stable COPD patients, but requires careful monitoring for complications due to its narrow therapeutic index and potential side effects 1, 3
Combination therapy with a long-acting β-agonist and an inhaled corticosteroid has been shown to reduce cough in long-term trials for patients with severe airflow obstruction or frequent exacerbations 1, 3

During acute COPD exacerbations, the European Respiratory Society recommends use of short-acting β-agonists or anticholinergic bronchodilators as first-line therapy 1, 4
A short course of systemic corticosteroids is recommended for acute exacerbations and may help with cough, though cough has not been specifically evaluated as an outcome in most studies 1, 3

Codeine and dextromethorphan can be effective for temporary suppression of troublesome cough, reducing cough counts by 40-60% in patients with chronic bronchitis 1, 5
Antitussive agents should only be used for short-term symptomatic relief when cough is particularly bothersome 1, 5

Currently available expectorants have not been proven effective for cough in chronic bronchitis and should not be used, according to the American College of Chest Physicians 1, 3
Oral corticosteroids are not recommended for stable COPD patients due to lack of evidence of benefit and well-known side effects 1, 3

Proper inhaler technique is essential for optimal medication delivery and efficacy, as emphasized by the European Respiratory Society 4, 7
Addressing the underlying cause of COPD, such as smoking cessation, is fundamental to reducing cough long-term, as recommended by the European Respiratory Society 5, 8